What determine a contemporary state and competitiveness of the russian farmaceutical industry
Abstract
The level of competitiveness of the Russian pharmaceutical industry is extremely low. The national pharmaceutical industry development is one of the priorities in the Government activity because it is connected with contemporaryrequirements of the economy of innovations, improves our people’s well-being and protects the inner market consumers. The strategy of the Russian pharmaceutical industry development up to 2020 which was adopted in 2009 and aimed to development of innovation in the industry failed. The article focuses on the different factors that determine possibilities for the local branded pharmaceutical business in Russia. It is the main issue of being competitive for the Russian pharmaceutical industry in the future.
About the Authors
A. A. Bekarev
Scientific Future Management, Koltsovo
Russian Federation
Russian Federation
S. V. Bekareva
Novosibirsk State University, Novosibirsk
Russian Federation
Russian Federation
References
1. Bekarev A., Bekareva S. An Approach to Assessment of Competitiveness of National Pharmaceutical Industry. Vestnik of Novosibirsk State University. Series: Social and Economic Sciences, 2014, vol. 14, iss. 4, p. 78–92. (in Russ.)
Review
For citations:
Bekarev A.A., Bekareva S.V. What determine a contemporary state and competitiveness of the russian farmaceutical industry. World of Economics and Management. 2015;15(1):23–31. (In Russ.)
Views:
93
Email this article 
